video library

Host: Jennifer Caudle, DO
Guest: Catherine Apicella, MPT, PYT-C, PRPC

With less and less primary care physicians partnering with physical therapists, it’s time we ask: are we doing ourselves—and our patients—a disservice by not taking advantage of this option? To find out, Dr. Jennifer Caudle sits down with physical therapist Catherine Apicella to discuss the often-overlooked benefits of physical therapy and how primary care physicians and physical therapists can work together to benefit their patients.

Host: Jennifer Caudle, DO
Guest: Catherine Apicella, MPT, PYT-C, PRPC

With less and less primary care physicians partnering with physical therapists, it’s time we ask: are we doing ourselves—and our patients—a disservice by not taking advantage of this option? To find out, Dr. Jennifer Caudle sits down with physical therapist Catherine Apicella to discuss the often-overlooked benefits of physical therapy and how primary care physicians and physical therapists can work together to benefit their patients.

Host: Jennifer Caudle, DO
Guest: Catherine Apicella, MPT, PYT-C, PRPC

Frustrating multiple sclerosis (MS) symptoms like urinary frequency and incontinence can be detrimental to a patient’s quality of life, but there are resources available to help. To explore the benefits of pelvic floor physical therapy for MS, Dr. Jennifer Caudle sits down with two special guests: physical therapist Catherine Apicella from CORE 3 Physical Therapy and her patient—and ReachMD’s very own employee—Crystal Gouldey.

Host: Jennifer Caudle, DO
Guest: Catherine Apicella, MPT, PYT-C, PRPC

Frustrating multiple sclerosis (MS) symptoms like urinary frequency and incontinence can be detrimental to a patient’s quality of life, but there are resources available to help. To explore the benefits of pelvic floor physical therapy for MS, Dr. Jennifer Caudle sits down with two special guests: physical therapist Catherine Apicella from CORE 3 Physical Therapy and her patient—and ReachMD’s very own employee—Crystal Gouldey.

Guest: Alexis Ogdie, MD, MSCE

Along with the management of psoriatic arthritis, many patients also struggle with multiple, underlying comorbidities, increasing the complexity of the disease. In a review of the associated comorbidities that can emerge from PsA, Dr. Alexis Ogdie brings another aspect to the forefront: the all-too-often underrecognized comorbidities and risk factors.

Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

Guest: Adrienne Rencic, MD, PhD

Many psoriatic arthritis patients struggle in determining the proper physician they should seek for treatment and care management. Since dermatologists are usually consulted first due to skin manifestations, it’s crucial that they are able to recognize the symptoms of PsA and know when to refer the patient to another specialist. Dr. Adrienne Rencic, a dermatologist in Glen Mills, PA, emphasizes the power of communication to achieve good coordination of care.

Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

Guest: Robin K. Dore, MD

Dr. Robin Dore joins us to answer some of the most frequently asked questions about PASI, like what these scores are, how they’re used, and how they affect the outcomes of your psoriatic arthritis patients.

Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

Guest: Robin K. Dore, MD

The emotional burden of psoriatic arthritis stems from the development of skin lesions, which can be extremely damaging to a patient’s personal and professional relationships as Dr. Robin Dore explains.

Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

Guest: Elizabeth Volkmann, MD, MS

When assessing for low or minimal disease activity in psoriatic arthritis patients, there are three things you need to consider: patient-centered criteria, physical examination findings, and laboratory measures. Explore how you can use this combination of outcome measurements in your practice with rheumatologist and clinical researcher at the Ronald Reagan Medical Center at UCLA, Dr. Elizabeth Volkmann.

Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

Guest: Elizabeth Volkmann, MD, MS

What matters most to your psoriatic arthritis patients? Knowing the answer plays a big role in any successful treat-to-target strategy, and thanks to these insights from Dr. Elizabeth Volkmann, you can ensure that you’re developing an approach that’s ideal for each individual patient. Dr. Volkmann is a rheumatologist and clinical researcher at the Ronald Reagan Medical Center at UCLA.

Beyond Skin Deep: Impacts of Psoriatic Arthritis is sponsored by Lilly. Content for this a non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

Host: David Weisman, MD
Guest: John Khoury, MD

For the first time, the FDA has approved a direct-to-consumer genetic test from 23andme that will inform patients if they are predisposed to diseases such as Parkinson’s, Alzheimer's, and Celiac Disease among others.

Proponents applaud this decision, saying this will allow for people to know their genetic health risks and be more proactive about their health. Others argue that this information doesn’t tell the whole story since predisposition doesn't reflect someone's ultimate risk or likelihood of developing a disease. What are the benefits and liabilities of consumers' access to genetic testing?

Host Dr. David Weisman, Director of Clinical Trials at Abington Neurological Associates, sits down with Dr. John Khoury, Associate Director at Abington Memorial Hospital Sleep Disorders Center, to debate the merits and pitfalls of direct-to-consumer genetic testing.

Host: David Weisman, MD
Guest: John Khoury, MD

For the first time, the FDA has approved a direct-to-consumer genetic test from 23andme that will inform patients if they are predisposed to diseases such as Parkinson’s, Alzheimer's, and Celiac Disease among others.

Proponents applaud this decision, saying this will allow for people to know their genetic health risks and be more proactive about their health. Others argue that this information doesn’t tell the whole story since predisposition doesn't reflect someone's ultimate risk or likelihood of developing a disease. What are the benefits and liabilities of consumers' access to genetic testing?

Host Dr. David Weisman, Director of Clinical Trials at Abington Neurological Associates, sits down with Dr. John Khoury, Associate Director at Abington Memorial Hospital Sleep Disorders Center, to debate the merits and pitfalls of direct-to-consumer genetic testing.

Host: Brian P. McDonough, MD, FAAFP
Guest: Allison Willis, MD

More men than women are diagnosed with Parkinson's Disease by almost a 2 to 1 margin. However, women receive supportive surgery less often than men, and their symptoms are more severe on average by the time surgical options are taken.

Host Brian McDonough chats with Dr. Allison Willis, Assistant Professor of Neurology at the Perelman School of Medicine at the University of Pennsylvania, about gender differences in diagnosing and managing Parkinson's Disease.

Discover how hearing loss in the US is growing and how it affects young and older people alike. Protect your patients' hearing with these tips and resources in an increasingly noisy world from Dr. John Iskander and Dr. William Murphy in this session of Beyond the Data.

Visit Dangerousdecibels.org to learn how to protect your hearing. Discover “How loud is too loud?”

In this educational activity, steering committee members, Dr. Jaume Sastre-Garriga and Dr. Antonio Uccelli, discuss establishing partnerships among practitioners for best patient outcomes.

This interview is supported by an educational grant from Merck KGaA, Darmstadt, Germany.

In this interview, Lawrence Sherman and Dr. Ralf Gold discusses the study, "Immunologic Effects of Metformin and Pioglitazone Treatment on Metabolic Syndrome and Multiple Sclerosis," which was led by researchers, Laura Negrotto and Dr. Raul Carrea. They will also discuss the impact of the drugs on clinical biomarkers and MRI, as well as future research on immunologic effects tied to MS.

This interview is supported by an educational grant from Merck KGaA, Darmstadt, Germany.

This lecture was given at the 360◦ of Fertility: Optimizing Clinical and Laboratory Approaches educational program in Sao Paulo, Brazil by Marcos Horton, MD.

This interview is supported by an educational grant from Merck KGaA, Darmstadt, Germany.

Dr. Edgardo Cristiano, from Buenos Aires, Argentina, will discuss policy issues in the management of MS specific to optimizing treatment options in this interview.

This interview is supported by an educational grant from Merck KGaA, Darmstadt, Germany.

This lecture was given at the 360◦ of Fertility: Optimizing Clinical and Laboratory Approaches educational program in Sao Paulo, Brazil by Marcos Horton, MD.

This interview is supported by an educational grant from Merck KGaA, Darmstadt, Germany.

This lecture was given at the 360◦ of Fertility: Optimizing Clinical and Laboratory Approaches educational program in Sao Paulo, Brazil by Sandro Esteves, MD, PhD.

This interview is supported by an educational grant from Merck KGaA, Darmstadt, Germany.